Kolexia
Tudesq Jean-Jacques
Anesthesie-réanimation
Hôpital Saint-Éloi
Montpellier, France
77 Activités
382 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Syndrome de libération de cytokines Tumeurs hématologiques COVID-19 Maladie grave Lymphome B diffus à grandes cellules Leucémies Sepsie

Industries

Roche
2 collaboration(s)
Dernière en 2023
Gilead
2 collaboration(s)
Dernière en 2022
BMS
1 collaboration(s)
Dernière en 2022
Celgene
1 collaboration(s)
Dernière en 2022

Dernières activités

Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
Annals of hematology   26 janvier 2024
HLH-JAK the First Open-Label, Phase II Study Evaluating Anti-JAK1 Itacitinib, for Non Severe HLH in Adults
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Propensity Score-Matched Analysis on the Outcomes of Brexucabtagene Autoleucel from Zuma-2 Study and Allogeneic Stem Cell Transplantation from the EBMT Database in Relapsed and Refractory Post-Btki Mantle Cell Lymphoma
65th ASH Annual Meeting Abstracts   02 novembre 2023
Invasive Fungal Infections after CAR T-Cell Therapy for B-Cell Lymphoma: A Study from the French Descart Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression
65th ASH Annual Meeting Abstracts   02 novembre 2023
Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC.
Bulletin du cancer   14 octobre 2023
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
Essai Clinique (Novartis)   25 septembre 2023
Impact of acute kidney injury occurrence in critical care on long-term prognosis in patients with hematological malignancies
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
PROGNOSTIC SCORING SYSTEMS FOR SEVERE CRS AND ICANS AFTER AUTOLOGOUS ANTI-CD19 CAR T CELLS IN LARGE B-CELL LYMPHOMA: A DESCAR-T REGISTRY STUDY FORM THE LYSA
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Frontal Intermittent Rhythmic Delta Activity Is a Useful Diagnostic Tool of Neurotoxicity After CAR T-Cell Infusion.
Neurology(R) neuroimmunology & neuroinflammation   14 avril 2023